Form 4 Filing for Actinium Pharmaceuticals, Inc.

Richard Steinhart, a director at Actinium Pharmaceuticals, Inc. (ATNM), reported a significant transaction on September 2, 2026. He acquired 62,800 shares of Common Stock and was granted 94,200 stock options. The Common Stock acquisition is noted as a grant of restricted stock units (RSUs) that vest over three years. The stock options vest and become exercisable in fifty equal monthly tranches, beginning on the grant date, with an exercise price of $1.00. Following these transactions, Steinhart directly owns 63,116 shares of Common Stock and 94,200 stock options. This filing, designated as Form 4, indicates a change in the reporting owner's holdings.